Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study is designed to evaluate if self-inserted intravaginal 2% lidocaine gel is effective at decreasing pain during intrauterine device insertion in nulliparous women.
Epistemonikos ID: 34d711b6ac320912455a877e9fc0e931bf573881
First added on: May 10, 2024